303 related articles for article (PubMed ID: 33979969)
1. [Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].
;
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):265-275. PubMed ID: 33979969
[No Abstract] [Full Text] [Related]
2. [Management of the chronic graft versus host disease: Guidelines from the Francophone society of bone marrow transplantation and cellular therapies (SFGM-TC)].
Magro L; Forcade E; Giraud C; Granata A; Parquet N; Rohrlich PS; Terriou L; Yakoub-Agha I; Beguin Y
Bull Cancer; 2017 Dec; 104(12S):S145-S168. PubMed ID: 29174321
[TBL] [Abstract][Full Text] [Related]
3. Optimal management of chronic graft-versus-host disease in children.
Jacobsohn DA
Br J Haematol; 2010 Aug; 150(3):278-92. PubMed ID: 20553274
[TBL] [Abstract][Full Text] [Related]
4. [Complications of hematopoietic stem cell transplantation and the treatment: graft-versus-host disease].
Kato A
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1337-43. PubMed ID: 16097589
[No Abstract] [Full Text] [Related]
5. [2018 update on chronic graft-versus-host disease].
Inamoto Y
Rinsho Ketsueki; 2018; 59(10):2300-2306. PubMed ID: 30305539
[TBL] [Abstract][Full Text] [Related]
6. How I treat chronic graft-versus-host disease.
Vogelsang GB
Blood; 2001 Mar; 97(5):1196-201. PubMed ID: 11222360
[TBL] [Abstract][Full Text] [Related]
7. Vulvovaginal Graft-Versus-Host Disease.
Kornik RI; Rustagi AS
Obstet Gynecol Clin North Am; 2017 Sep; 44(3):475-492. PubMed ID: 28778644
[TBL] [Abstract][Full Text] [Related]
8. Biology and management of chronic graft-versus-host disease.
Martin PJ; Pavletic SZ
Cancer Treat Res; 2009; 144():277-98. PubMed ID: 19779885
[No Abstract] [Full Text] [Related]
9. [Complications of hematopoietic stem cell transplantation: physiopathology and management. 2. Graft-versus-host disease (GVHD)].
Morishita Y
Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1502-9. PubMed ID: 9780678
[No Abstract] [Full Text] [Related]
10. Clinical applications for biomarkers of acute and chronic graft-versus-host disease.
Levine JE; Paczesny S; Sarantopoulos S
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S116-24. PubMed ID: 22226094
[TBL] [Abstract][Full Text] [Related]
11. Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.
Chronic GVHD Consortium
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1727-1732. PubMed ID: 29476954
[TBL] [Abstract][Full Text] [Related]
12. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
13. Clinical update on graft-versus-host disease in children.
Goddard DS; Horn BN; McCalmont TH; Cordoro KM
Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598
[TBL] [Abstract][Full Text] [Related]
14. Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management.
Hull K; Kerridge I; Avery S; McCullough M; Ritchie D; Szer J
Intern Med J; 2015 Jul; 45(7):702-10. PubMed ID: 26134695
[TBL] [Abstract][Full Text] [Related]
15. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
Curtis LM; Datiles MB; Steinberg SM; Mitchell SA; Bishop RJ; Cowen EW; Mays J; McCarty JM; Kuzmina Z; Pirsl F; Fowler DH; Gress RE; Pavletic SZ
Haematologica; 2015 Sep; 100(9):1228-36. PubMed ID: 26088932
[TBL] [Abstract][Full Text] [Related]
16. Acute Graft-Versus-Host Disease: A Brief Review.
Aladağ E; Kelkitli E; Göker H
Turk J Haematol; 2020 Feb; 37(1):1-4. PubMed ID: 31475512
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Remberger M
Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922
[No Abstract] [Full Text] [Related]
18. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.
Pavletic SZ; Lee SJ; Socie G; Vogelsang G
Bone Marrow Transplant; 2006 Nov; 38(10):645-51. PubMed ID: 16980994
[TBL] [Abstract][Full Text] [Related]
19. Chronic graft-vs-host disease.
Bhushan V; Collins RH
JAMA; 2003 Nov; 290(19):2599-603. PubMed ID: 14625337
[No Abstract] [Full Text] [Related]
20. Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report.
Cocito F; Mangiacavalli S; Bernasconi P; Colombo AA; Caldera D; Cartia CS; Ganzetti M; Troletti D; Cazzola M; Corso A
Leuk Lymphoma; 2017 Nov; 58(11):2770-2771. PubMed ID: 28287281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
